Inventor · disambiguated record
Kim Leslie O'Neill
Also filed as: O'NEILL KIM · O'NEILL KIM L · O'NEILL KIM LESLIE
13 granted patents·7 pending applications·90 citations·filing 1995–2024
91Inventor score
Files withONEILL KIM LESLIE8THUNDER BIOTECH INC6UNIV BRIGHAM YOUNG4LALLATIN NATHANIEL1O'NEILL KIM LESLIE1
Top patents by PatentIndex Score
20 records- 0195US10415017B2Transgenic macrophages, chimeric antigen receptors, and associated methodsTHUNDER BIOTECH INC·Filed 2017·Granted Sep 17, 2019·21 cites·17 claims
- 0294US10434153B1Use of car and bite technology coupled with an scFv from an antibody against human thymidine kinase 1 to specifically target tumorsONEILL KIM LESLIE·Filed 2016·Granted Oct 8, 2019·9 cites·11 claims
- 0390US10889803B2Transgenic macrophages, chimeric antigen receptors, and associated methodsTHUNDER BIOTECH INC·Filed 2019·Granted Jan 12, 2021·3 cites·12 claims
- 0489US12076378B2Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumorsONEILL KIM LESLIE·Filed 2021·Granted Sep 3, 2024·1 cites·8 claims
- 0589US11052138B2Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumorsONEILL KIM LESLIE·Filed 2018·Granted Jul 6, 2021·3 cites·6 claims
- 0687US2025215075A1Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target TumorsONEILL KIM LESLIE·Filed 2024·Application pending·0 cites
- 0786US11352439B2Macrophage CAR (MOTO-CAR) in immunotherapyONEILL KIM LESLIE·Filed 2016·Granted Jun 7, 2022·3 cites·12 claims
- 0884US7837998B2Anti-cancer activity of an anti-thymidine kinase monoclonal antibodyLALLATIN NATHANIEL·Filed 2005·Granted Nov 23, 2010·11 cites·11 claims
- 0982US2025075181A1Transgenic Macrophages, Chimeric Antigen Receptors, and Associated MethodsTHUNDER BIOTECH INC·Filed 2024·Application pending·0 cites
- 1081US7311906B2Anti-viral activity of an anti-thymidine kinase monoclonal antibodyUNIV BRIGHAM YOUNG·Filed 2005·Granted Dec 25, 2007·6 cites·11 claims
- 1178US5698409AMonoclonal antibodies to thymidine kinase 1 and uses in diagnostic and therapeutic applicationsUNIV BRIGHAM YOUNG·Filed 1995·Granted Dec 16, 1997·32 cites·26 claims
- 1273US12024719B2Transgenic macrophages, chimeric antigen receptors, and associated methodsTHUNDER BIOTECH INC·Filed 2021·Granted Jul 2, 2024·0 cites·11 claims
- 1370US10821162B2Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumorsONEILL KIM LESLIE·Filed 2018·Granted Nov 3, 2020·0 cites·9 claims
- 1469US10828355B2Use of car and bite technology coupled with an ScFv from an antibody against human thymidine kinase 1 to specifically target tumorsONEILL KIM LESLIE·Filed 2018·Granted Nov 10, 2020·0 cites·8 claims
- 1568US2025032613A1Systems and Methods for Treating Graves' DiseaseUNIV BRIGHAM YOUNG·Filed 2024·Application pending·0 cites
- 1662US2025082679A1Method of Targeting Cells and Associated CompositionsTHUNDER BIOTECH INC·Filed 2022·Application pending·0 cites
- 1760US2022372170A1Macrophage CAR (MOTO-CAR) In ImmunotherapyONEILL KIM LESLIE·Filed 2022·Application pending·0 cites
- 1856US9267948B2Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereofO'NEILL KIM LESLIE·Filed 2010·Granted Feb 23, 2016·1 cites·2 claims
- 1949US2021052643A1Modified macrophages and macrophage precursors and associated methodsTHUNDER BIOTECH INC·Filed 2018·Application pending·0 cites
- 2043US2010266495A1Anti-Cancer Activity of an Anti-Thymidine Kinase Monoclonal AntibodyUNIV BRIGHAM YOUNG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kim Leslie O'Neill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →